OpenEye Scientific is now part of Cadence

Partnerships and Engagements

OpenEye actively seeks partnerships and engagements with like-minded organizations looking to advance today's molecular-design technologies.

Our partners include:

Specifica - in antibody discovery
Gaussian - in quantum modeling

Together, we create new methodologies, integrate proprietary methods, secure intellectual property (IP), and more.

To inquire about working with OpenEye on your endeavors, please contact us at info@eyesopen.com.

Specifica Testimonial

Resources

Glimpse the Future through News, Events, Webinars and more

News

Cadence Announces New Life Sciences Leadership

Cadence Molecular Sciences (OpenEye) (CMS)—a business unit of Cadence Design Systems, Inc. Corporate Vice President, Anthony Nicholls, PhD, has announced his retirement as of January, 2025.

Webinar

miniWebinar: Opening up the druggable universe one cryptic pocket at a time

In our first miniWEBINAR of 2025 we were talking about a computational workflow to validate difficult-to-drug protein targets in "Opening up the druggable universe one cryptic pocket at a time" session presented by David LeBard, Head of Enhanced Sampling at OpenEye, Cadence Molecular Sciences,

Event

Cocktails & Molecules

News

Expanding Orion’s Capabilities with AI

Webinar

miniWebinar: Optimizing lead compounds with efficient binding free energy calculations

cta-bg-desktop

cta-bg-mobile

Get Started

Accelerate your Science with OpenEye

Let’s Connect